These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 1766212)
1. [A new concept of the development of glucocorticoid dependence in autoimmune diseases]. Pytskiĭ VI Klin Med (Mosk); 1991 Oct; 69(10):3-10. PubMed ID: 1766212 [No Abstract] [Full Text] [Related]
2. [Immunosuppressive drugs and the lymphocytes]. Tsubura E; Saijo N Saishin Igaku; 1969 Aug; 24(8):1688-94. PubMed ID: 4902063 [No Abstract] [Full Text] [Related]
3. [Treatment of autoimmune hepatic diseases]. Bueverov AO Klin Med (Mosk); 2004; 82(10):62-6. PubMed ID: 15584604 [TBL] [Abstract][Full Text] [Related]
4. [The effect of immunocorrective therapy on immunity in patients with idiopathic autoimmune cytopenias]. Tishchenko LM Vrach Delo; 1991 Aug; (8):60-3. PubMed ID: 1949738 [TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids in the medical management of Graves' ophthalmopathy. Hart RH; Perros P Minerva Endocrinol; 2003 Sep; 28(3):223-31. PubMed ID: 14605604 [TBL] [Abstract][Full Text] [Related]
6. Treatment of life-threatening autoimmune diseases with myeloablative doses of immunosuppressive agents: experimental background and rationale for ABMT. Slavin S Bone Marrow Transplant; 1993 Jul; 12(1):85-8. PubMed ID: 8104072 [TBL] [Abstract][Full Text] [Related]
7. [Immunosuppressive treatment of multiple sclerosis (review of the literature]. Neretin VIa; Kir'iakov VA; Sapfirova VA Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(2):119-26. PubMed ID: 2160156 [No Abstract] [Full Text] [Related]
8. Targeting the side effects of steroid therapy in autoimmune diseases: the role of GILZ. Fan H; Morand EF Discov Med; 2012 Feb; 13(69):123-33. PubMed ID: 22369971 [TBL] [Abstract][Full Text] [Related]
9. An overview of the adverse reactions to adrenal corticosteroids. Frauman AG Adverse Drug React Toxicol Rev; 1996 Nov; 15(4):203-6. PubMed ID: 9113247 [TBL] [Abstract][Full Text] [Related]
10. BAFF-targeting therapy, a promising strategy for treating autoimmune diseases. Sun J; Lin Z; Feng J; Li Y; Shen B Eur J Pharmacol; 2008 Nov; 597(1-3):1-5. PubMed ID: 18793632 [TBL] [Abstract][Full Text] [Related]
11. [A method of determining the glucocorticoid-resistant fraction of the lymphocytes in the peripheral blood and lymphoid organs]. Pytskiĭ VI; Khodakova IA; Baliakin IuV; Arutiunova EE; Egorova MV Patol Fiziol Eksp Ter; 1986; (5):82-5. PubMed ID: 2432454 [No Abstract] [Full Text] [Related]
12. [Current trends in the study of immunosuppressive agents]. Uteshev BS Farmakol Toksikol; 1981; 44(1):5-12. PubMed ID: 6455303 [TBL] [Abstract][Full Text] [Related]
18. Results of steroid-based therapy for the hepatitis C-autoimmune hepatitis overlap syndrome. Schiano TD; Te HS; Thomas RM; Hussain H; Bond K; Black M Am J Gastroenterol; 2001 Oct; 96(10):2984-91. PubMed ID: 11693337 [TBL] [Abstract][Full Text] [Related]
19. Leflunomide, an immunorestoring drug for the therapy of autoimmune disorders, especially rheumatoid arthritis. Bartlett RR; Brendel S; Zielinski T; Schorlemmer HU Transplant Proc; 1996 Dec; 28(6):3074-8. PubMed ID: 8962190 [No Abstract] [Full Text] [Related]
20. Glucocorticoids: action and new therapeutic insights in rheumatoid arthritis. Kirwan J; Power L Curr Opin Rheumatol; 2007 May; 19(3):233-7. PubMed ID: 17414948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]